Therapeutics: Chemokine CXC motif ligand 1 (CXCL1; GRO; MGSA); CXC chemokine receptor 1 (CXCR1); CXCR2 (IL8RB)

Cancer

INDICATION: Prostate cancer

Patient sample and mouse studies suggest inhibiting CXCL1-CXCR1/CXCR2 signaling could help treat prostate cancer in obese patients.

Read the full 194 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE